Protinhi Therapeutics is developing novel antiviral drugs, to do this successfully and to mitigate the risk for venture capital investors it is essential to have access to capital from grants from national and international bodies.
- Bernd van Buuren, CEO Protinhi Therapeutics
GSC helps you identify grants and innovation credits.
Non-dilutive funding helps your venture receive money for scaling your company without giving up ownership. Together with you, we will develop a personalized grant strategy for your company. The scheme will entail both R&D as well as commercial development grant opportunities.